Transcriptional ERRγ 2-mediated activation is regulated by sentrin-specific proteases

Biochemical Journal

Volumn 419, Issue 1, 2009, Pages 167-176

  Hentschke, Moritz ^a   Süsens, Ute ^a   Borgmeyer, Uwe ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Activation function 1 (AF 1); Oestrogen receptorrelated receptor 2 (ERR 2); Orphan nuclear receptor; Sentrin; Small ubiquitin related modifier (SUMO); Transcription

Indexed keywords

ACTIVATION FUNCTION-1 (AF-1); ACTIVATION FUNCTIONS; CHARGED AMINO ACIDS; CO-EXPRESSION; CONSTITUTIVELY ACTIVES; DE-REPRESSION; DNA-BINDING DOMAIN; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FUSION PROTEINS; HIGH RESOLUTION; LYSINE RESIDUES; MUTATIONAL ANALYSIS; NUCLEAR RECEPTORS; OESTROGEN RECEPTORS; ORPHAN NUCLEAR RECEPTOR; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; REVERSIBLE PHOSPHORYLATION; SENTRIN; SMALL UBIQUITIN-RELATED MODIFIER (SUMO); SMALL UBIQUITIN-RELATED MODIFIERS; SUMOYLATION;

AMINES; AMINO ACIDS; CYTOLOGY; ELECTROPHORETIC MOBILITY; NUCLEIC ACIDS; ORGANIC ACIDS; PHOSPHORYLATION; TRANSCRIPTION; TRANSCRIPTION FACTORS;

CHEMICAL ACTIVATION;

ESTROGEN RELATED RECEPTOR GAMMA 2; LYSINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; PROTEINASE; SENTRIN SPECIFIC PROTEASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ESTROGEN RECEPTOR; MULTIENZYME COMPLEX; SENP2 PROTEIN, MOUSE; SUMO PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; SUMOYLATION; TRANSCRIPTION REGULATION; ANIMAL; CELL LINE; CHEMISTRY; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOUSE; MUTATION; PHOSPHORYLATION; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

ANIMALS; CELL LINE; CELL LINE, TUMOR; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; MICE; MULTIENZYME COMPLEXES; MUTATION; PHOSPHORYLATION; RECEPTORS, ESTROGEN; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 62749121068     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20081556     Document Type: Article

References (51)

1. Faus, H. and Haendler, B. (2006) Post-translational modifications of steroid receptors. Biomed. Pharmacother. 60, 520-528
2. Fu, M., Wang, C., Zhang, X. and Pestell, R. G. (2004) Acetylation of nuclear receptors in cellular growth and apoptosis. Biochem. Pharmacol. 68, 1199-1208
3. Geiss-Friedlander, R. and Melchior, F. (2007) Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 8, 947-956
4. Meulmeester, E. and Melchior, F. (2008) Cell biology: SUMO. Nature 452, 709-711
5. Anckar, J. and Sistonen, L. (2007) SUMO: getting it on. Biochem. Soc. Trans. 35, 1409-1413
6. Lyst, M. J. and Stancheva, I. (2007) A role for SUMO modification in transcriptional repression and activation. Biochem. Soc. Trans. 35, 1389-1392
7. Hietakangas, V., Anckar, J., Blomster, H. A., Fujimoto, M., Palvimo, J. J., Nakai, A. and Sistonen, L. (2006) PDSM, a motif for phosphorylation-dependent SUMO modification. Proc. Natl. Acad. Sci. U.S.A. 103, 45-50
8. Stankovic-Valentin, N., Deltour, S., Seeler, J., Pinte, S., Vergoten, G., Guerardel, C., Dejean, A. and Leprince, D. (2007) An acetylation/ deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity. Mol. Cell. Biol. 27, 2661-2675
9. Yang, X. J. and Gregoire, S. (2006) A recurrent phospho-sumoyl switch in transcriptional repression and beyond. Mol. Cell 23, 779-786
10. Gregoire, S., Tremblay, A. M., Xiao, L., Yang, Q., Ma, K., Nie, J., Mao, Z., Wu, Z., Giguere, V. and Yang, X. J. (2006) Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation. J. Biol. Chem. 281, 4423-4433
11. Hietakangas, V., Ahlskog, J. K., Jakobsson, A. M., Hellesuo, M., Sahlberg, N. M., Holmberg, C. I., Mikhailov, A., Palvimo, J. J., Pirkkala, L. and Sistonen, L. (2003) Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1. Mol. Cell. Biol. 23, 2953-2968
12. Shalizi, A., Gaudilliere, B., Yuan, Z., Stegmuller, J., Shirogane, T., Ge, Q., Tan, Y., Schulman, B., Harper, J. W. and Bonni, A. (2006) A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation. Science (New York) 311, 1012-1017
13. Guo, B., Yang, S. H., Witty, J. and Sharrocks, A. D. (2007) Signalling pathways and the regulation of SUMO modification. Biochem. Soc. Trans. 35, 1414-1418
14. Floyd, Z. E. and Stephens, J. M. (2004) Control of peroxisome proliferator-activated receptor gamma2 stability and activity by SUMOylation. Obes. Res. 12, 921-928
15. Ohshima, T., Koga, H. and Shimotohno, K. (2004) Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification. J. Biol. Chem. 279, 29551-29557
16. Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G. and Glass, C. K. (2005) A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 437, 759-763
17. Yamashita, D., Yamaguchi, T., Shimizu, M., Nakata, N., Hirose, F. and Osumi, T. (2004) The transactivating function of peroxisome proliferator-activated receptor gamma is negatively regulated by SUMO conjugation in the amino-terminal domain. Genes Cells 9, 1017-1029
18. Yang, S. H., Galanis, A., Witty, J. and Sharrocks, A. D. (2006) An extended consensus motif enhances the specificity of substrate modification by SUMO. EMBO J. 25, 5083-5093
19. Gong, L., Millas, S., Maul, G. G. and Yeh, E. T. (2000) Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J. Biol. Chem. 275, 3355-3359
20. Mukhopadhyay, D. and Dasso, M. (2007) Modification in reverse: the SUMO proteases. Trends Biochem. Sci. 32, 286-295
21. Ihara, M., Koyama, H., Uchimura, Y., Saitoh, H. and Kikuchi, A. (2007) Noncovalent binding of small ubiquitin-related modifier (SUMO) protease to SUMO is necessary for enzymatic activities and cell growth. J. Biol. Chem. 282, 16465-16475
22. Drag, M., Mikolajczyk, J., Krishnakumar, I. M., Huang, Z. and Salvesen, G. S. (2008) Activity profiling of human deSUMOylating enzymes (SENPs) with synthetic substrates suggests an unexpected specificity of two newly characterized members of the family. Biochem. J. 409, 461-469
23. Süsens, U., Hermans-Borgmeyer, I. and Borgmeyer, U. (2000) Alternative splicing and expression of the mouse estrogen receptor-related receptor gamma. Biochem. Biophys. Res. Commun. 267, 532-535
24. Hentschke, M. and Borgmeyer, U. (2003) Identification of PNRC2 and TLE1 as activation function-1 cofactors of the orphan nuclear receptor ERRγ. Biochem. Biophys. Res. Commun. 312, 975-982
25. Reference deleted
26. Bailey, D. and O'Hare, P. (2002) Herpes simplex virus 1 ICP0 co-localizes with a SUMO-specific protease. J. Gen. Virol. 83, 2951-2964
27. Strausberg, R. L., Feingold, E. A., Grouse, L. H., Derge, J. G., Klausner, R. D., Collins, F. S., Wagner, L., Shenmen, C. M., Schuler, G. D., Altschul, S. F. et al. (2002) Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. U.S.A. 99, 16899-16903
28. Hentschke, M., Süsens, U. and Borgmeyer, U. (2002) Domains of ERRgamma that mediate homodimerization and interaction with factors stimulating DNA binding. Eur. J. Biochem. 269, 4086-4097
29. Huppunen, J. and Aarnisalo, P. (2004) Dimerization modulates the activity of the orphan nuclear receptor ERRgamma. Biochem. Biophys. Res. Commun. 314, 964-970
30. Hentschke, M., Süsens, U. and Borgmeyer, U. (2002) PGC-1 and PERC, coactivators of the estrogen receptor-related receptor. Biochem. Biophys. Res. Commun. 299, 872-879
31. Kamei, Y., Ohizumi, H., Fujitani, Y., Nemoto, T., Tanaka, T., Takahashi, N., Kawada, T., Miyoshi, M., Ezaki, O. and Kakizuka, A. (2003) PPARgamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity. Proc. Natl. Acad. Sci. U.S.A. 100, 12378-12383
32. Bailey, D. and O'Hare, P. (2004) Characterization of the localization and proteolytic activity of the SUMO-specific protease, SENP1. J. Biol. Chem. 279, 692-703
33. Vu, E. H., Kraus, R. J. and Mertz, J. E. (2007) Phosphorylation-dependent sumoylation of estrogen-related receptor alpha1. Biochemistry 46, 9795-9804
34. Tremblay, A. M., Wilson, B. J., Yang, X. J. and Giguère, V. (2008) Phosphorylation-dependent sumoylation regulates estrogen-related receptor-alpha and -gamma transcriptional activity through a synergy control motif. Mol. Endocrinol. 22, 570-584
35. Kuo, H. Y., Chang, C. C., Jeng, J. C., Hu, H. M., Lin, D. Y., Maul, G. G., Kwok, R. P. and Shih, H. M. (2005) SUMO modification negatively modulates the transcriptional activity of CREB-binding protein via the recruitment of Daxx. Proc. Natl. Acad. Sci. U.S.A. 102, 16973-16978
36. Lin, D. Y., Huang, Y. S., Jeng, J. C., Kuo, H. Y., Chang, C. C., Chao, T. T., Ho, C. C., Chen, Y. C., Lin, T. P., Fang, H. I. et al. (2006) Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol. Cell 24, 341-354
37. Clark-Lewis, I., Sanghera, J. S. and Pelech, S. L. (1991) Definition of a consensus sequence for peptide substrate recognition by p44mpk, the meiosis-activated myelin basic protein kinase. J. Biol. Chem. 266, 15180-15184
38. Gonzalez, F. A., Raden, D. L. and Davis, R. J. (1991) Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. J. Biol. Chem. 266, 22159-22163
39. Liu, B. and Shuai, K. (2008) Regulation of the sumoylation system in gene expression. Curr. Opin. Cell Biol. 20, 288-293
40. Palvimo, J. J. (2007) PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription. Biochem. Soc. Trans. 35, 1405-1408
41. Kotaja, N., Karvonen, U., Janne, O. A. and Palvimo, J. J. (2002) PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol. Cell. Biol. 22, 5222-5234
42. Janne, O. A., Moilanen, A. M., Poukka, H., Rouleau, N., Karvonen, U., Kotaja, N., Hakli, M. and Palvimo, J. J. (2000) Androgen-receptor-interacting nuclear proteins. Biochem. Soc. Trans. 28, 401-405
43. Kotaja, N., Aittomaki, S., Silvennoinen, O., Palvimo, J. J. and Janne, O. A. (2000) ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation. Mol. Endocrinol. 14, 1986-2000
44. Gan-Erdene, T., Nagamalleswari, K., Yin, L., Wu, K., Pan, Z. Q. and Wilkinson, K. D. (2003) Identification and characterization of DEN1, a deneddylase of the ULP family. J. Biol. Chem. 278, 28892-28900
45. Mendoza, H. M., Shen, L. N., Botting, C., Lewis, A., Chen, J., Ink, B. and Hay, R. T. (2003) NEDP1, a highly conserved cysteine protease that deNEDDylates Cullins. J. Biol. Chem. 278, 25637-25643
46. Wu, K., Yamoah, K., Dolios, G., Gan-Erdene, T., Tan, P., Chen, A., Lee, C. G., Wei, N., Wilkinson, K. D., Wang, R. and Pan, Z. Q. (2003) DEN1 is a dual function protease capable of processing the C terminus of Nedd8 and deconjugating hyper-neddylated CUL1. J. Biol. Chem. 278, 28882-28891
47. Drag, M. and Salvesen, G. S. (2008) DeSUMOylating enzymes - SENPs. IUBMB Life 60, 734-742
48. Lima, C. D. and Reverter, D. (2008) Structure of the human SENP7 catalytic domain and poly-SUMO deconjugation activities for SENP6 and SENP7. J. Biol. Chem. 283, 32045-32055
49. Feige, J. N. and Auwerx, J. (2007) Transcriptional coregulators in the control of energy homeostasis. Trends Cell Biol. 17, 292-301
50. Ariazi, E. A. and Jordan, V. C. (2006) Estrogen-related receptors as emerging targets in cancer and metabolic disorders. Curr. Top. Med. Chem. 6, 203-215
51. Yu, S., Wang, X., Ng, C. F., Chen, S. and Chan, F. L. (2007) ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer. Cancer Res. 67, 4904-4914